{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:54:34Z","timestamp":1792857274776,"version":"4.5.0"},"reference-count":78,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,1,1]]},"DOI":"10.2169\/internalmedicine.9336-22","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T22:13:04Z","timestamp":1646431984000},"page":"11-19","source":"Crossref","is-referenced-by-count":7,"title":["Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease?"],"prefix":"10.2169","volume":"62","author":[{"given":"Naoki","family":"Morito","sequence":"first","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 390: 1888-1917, 2017.","DOI":"10.1016\/S0140-6736(17)30788-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease: a systematic review and meta-analysis. PLoS One 11: e0158765, 2016.","DOI":"10.1371\/journal.pone.0158765"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Berger K, Moeller MJ. Podocytopenia, parietal epithelial cells and glomerulosclerosis. Nephrol Dial Transplant 29: 948-950, 2014.","DOI":"10.1093\/ndt\/gft511"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wiggins JE, Goyal M, Sanden SK, et al. Podocyte hypertrophy, &quot;adaptation&quot;, and &quot;decompensation&quot; associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005.","DOI":"10.1681\/ASN.2005050488"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marshall CB, Shankland SJ. Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 102: 39-48, 2006.","DOI":"10.1159\/000088400"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005.","DOI":"10.1681\/ASN.2005010055"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol 11: 76-87, 2015.","DOI":"10.1038\/nrneph.2014.216"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Usui T, Morito N, Shawki HH, et al. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis. Kidney Int 98: 391-403, 2020.","DOI":"10.1016\/j.kint.2020.02.038"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Morito N, Yoh K, Ojima M, et al. Overexpression of Mafb in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 25: 2546-2557, 2014.","DOI":"10.1681\/ASN.2013090993"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S. v-maf, a viral oncogene that encodes a &quot;leucine zipper&quot; motif. Proc Natl Acad Sci USA 86: 7711-7715, 1989.","DOI":"10.1073\/pnas.86.20.7711"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kataoka K, Noda M, Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol 14: 700-712, 1994.","DOI":"10.1128\/mcb.14.1.700-712.1994"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yoshida T, Ohkumo T, Ishibashi S, Yasuda K. The 5&apos;-AT-rich half-site of Maf recognition element: a functional target for bZIP transcription factor Maf. Nucleic Acids Res 33: 3465-3478, 2005.","DOI":"10.1093\/nar\/gki653"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Motohashi H, Katsuoka F, Shavit JA, Engel JD, Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell 103: 865-875, 2000.","DOI":"10.1016\/S0092-8674(00)00190-2"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367: 568-572, 1994.","DOI":"10.1038\/367568a0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takahashi S. Functional analysis of large MAF transcription factors and elucidation of their relationships with human diseases. Exp Anim 70: 264-271, 2021.","DOI":"10.1538\/expanim.21-0027"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hamada M, Tsunakawa Y, Jeon H, Yadav MK, Takahashi S. Role of MafB in macrophages. Exp Anim 69: 1-10, 2020.","DOI":"10.1538\/expanim.19-0076"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Stewart AK, Bergsagel PL, Greipp PR, et al. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia 21: 529-534, 2007.","DOI":"10.1038\/sj.leu.2404516"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Moriguchi T, Hamada M, Morito N, et al. MafB is essential for renal development and F4\/80 expression in macrophages. Mol Cell Biol 26: 5715-5727, 2006.","DOI":"10.1128\/MCB.00001-06"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kestil\u00e4 M, Lenkkeri U, M\u00e4nnikk\u00f6 M, et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998.","DOI":"10.1016\/S1097-2765(00)80057-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ruotsalainen V, Ljungberg P, Wartiovaara J, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 96: 7962-7967, 1999.","DOI":"10.1073\/pnas.96.14.7962"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bierzynska A, Soderquest K, Dean P, et al. <i>MAGI2<\/i> mutations cause congenital nephrotic syndrome. J Am Soc Nephrol 28: 1614-1621, 2017.","DOI":"10.1681\/ASN.2016040387"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Liang W, Yamahara K, Hernando-Erhard C, et al. A reciprocal regulation of spermidine and autophagy in podocytes maintains the filtration barrier. Kidney Int 98: 1434-1448, 2020.","DOI":"10.1016\/j.kint.2020.06.016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Reddy AT, Lakshmi SP, Banno A, Reddy RC. Role of GPx3 in PPAR\u03b3-induced protection against COPD-associated oxidative stress. Free Radic Biol Med 126: 350-357, 2018.","DOI":"10.1016\/j.freeradbiomed.2018.08.014"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tanaka E, Asanuma K, Kim E, et al. Notch2 activation ameliorates nephrosis. Nat Commun 5: 3296, 2014.","DOI":"10.1038\/ncomms4296"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zankl A, Duncan EL, Leo PJ, et al. Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB. Am J Hum Genet 90: 494-501, 2012.","DOI":"10.1016\/j.ajhg.2012.01.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Park JG, Tischfield MA, Nugent AA, et al. Loss of the MafB function in humans and mice causes Duane syndrome, aberrant extraocular muscle innervation, and inner-ear defects. Am J Hum Genet 98: 1220-1227, 2016.","DOI":"10.1016\/j.ajhg.2016.03.023"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sato Y, Tsukaguchi H, Morita H, et al. A mutation in transcription factor MAFB causes focal segmental glomerulosclerosis with duane retraction syndrome. Kidney Int 94: 396-407, 2018.","DOI":"10.1016\/j.kint.2018.02.025"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Klein C, Bellity J, Finidori G, Glorion C, Pannier S. Multicentric carpotarsal osteolysis syndrome: long-term follow-up of three patients. Skeletal Radiol 47: 1015-1019, 2018.","DOI":"10.1007\/s00256-018-2874-z"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Zhuang L, Adler S, Aeberli D, Villiger PM, Trueb B. 2017. Identification of a MAFB mutation in a patient with multicentric carpotarsal osteolysis. Swiss Med Wkly 147: w14529, 2017.","DOI":"10.4414\/smw.2017.14529"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Herath NI, Rocques N, Garancher A, Eych\u00e8ne A, Pouponnot C. 2014. GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target. Blood Cancer J 4: e175, 2014.","DOI":"10.1038\/bcj.2013.67"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Connor A, Highton J, Hung NA, Dunbar J, MacGinley R, Walker R. Multicentric carpal-tarsal osteolysis with nephropathy treated successfully with cyclosporine A: a case report and literature review. Am J Kidney Dis 50: 649-654, 2007.","DOI":"10.1053\/j.ajkd.2007.06.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Park PG, Kim KH, Hyun HS, et al. Three cases of multicentric carpotarsal osteolysis syndrome: a case series. BMC Med Genet 19: 164, 2018.","DOI":"10.1186\/s12881-018-0682-x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. N\u00e4rhi A, Fernandes A, Toiviainen-Salo S, et al. A family with partially penetrant multicentric carpotarsal osteolysis due to gonadal mosaicism: first reported case. Am J Med Genet A 185: 2477-2481, 2021.","DOI":"10.1002\/ajmg.a.62257"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Tsunakawa Y, Hamada M, Matsunaga Y, et al. Mice harboring an MCTO mutation exhibit renal failure resembling nephropathy in human patients. Exp Anim 68: 103-111, 2019.","DOI":"10.1538\/expanim.18-0093"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kanai M, Jeon H, Ojima M, et al. Phenotypic analysis of mice carrying human-type MAFB p.Leu239Pro mutation. Biochem Biophys Res Commun 523: 452-457, 2020.","DOI":"10.1016\/j.bbrc.2019.12.033"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kaimori JY, Mori T, Namba-Hamano T, et al. Cyclosporine A treatment of proteinuria in a new case of MAFB-associated glomerulopathy without extrarenal involvement: a case report. Nephron 145: 445-450, 2021.","DOI":"10.1159\/000516248"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. De Vriese AS, Sethi S, Nath KA, Glassock RJ, Fervenza FC. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol 29: 759-774, 2018.","DOI":"10.1681\/ASN.2017090958"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997.","DOI":"10.1172\/JCI119163"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ratelade J, Arrondel C, Hamard G, et al. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. Hum Mol Genet 19: 1-15, 2010.","DOI":"10.1093\/hmg\/ddp462"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. White JT, Zhang B, Cerqueira DM, Tran U, Wessely O. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in <i>Xenopus<\/i>. Development 137: 1863-1873, 2010.","DOI":"10.1242\/dev.042887"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kaltenis P, Schumacher V, Jankauskiene A, Laurinavicius A, Royer-Pokora B. Slow progressive FSGS associated with an F392L WT1 mutation. Pediatr Nephrol 19: 353-356, 2004.","DOI":"10.1007\/s00467-003-1372-1"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Mucha B, Ozaltin F, Hinkes BG, et al. Mutations in the Wilms&apos; tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59: 325-331, 2006.","DOI":"10.1203\/01.pdr.0000196717.94518.f0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA. WT1 regulates the expression of the major glomerular podocyte membrane protein podocalyxin. Curr Biol 11: 1805-1809, 2001.","DOI":"10.1016\/S0960-9822(01)00560-7"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Guo G, Morrison DJ, Licht JD, Quaggin SE. WT1 activates a glomerular-specific enhancer identified from the human nephrin gene. J Am Soc Nephrol 15: 2851-2856, 2004.","DOI":"10.1097\/01.ASN.0000143474.91362.C4"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Gao F, Maiti S, Sun G, et al. The Wt1+\/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome. Mol Cell Biol 24: 9899-9910, 2004.","DOI":"10.1128\/MCB.24.22.9899-9910.2004"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Morrison AA, Viney RL, Saleem MA, Ladomery MR. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 295: F12-F17, 2008.","DOI":"10.1152\/ajprenal.00597.2007"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol 21: 1653-1660, 2006.","DOI":"10.1007\/s00467-006-0208-1"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Gbadegesin R, Hinkes BG, Hoskins BE, et al. Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23: 1291-1297, 2008.","DOI":"10.1093\/ndt\/gfm759"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Chernin G, Vega-Warner V, Schoeb DS, et al. Genotype\/phenotype correlation in nephrotic syndrome caused by WT1 mutations. Clin J Am Soc Nephrol 5: 1655-1662, 2010.","DOI":"10.2215\/CJN.09351209"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Royer-Pokora B, Beier M, Henzler M, et al. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype\/phenotype correlations for Wilms tumor development. Am J Med Genet A 127A: 249-257, 2004.","DOI":"10.1002\/ajmg.a.30015"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Denamur E, Bocquet N, Mougenot B, et al. Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases. J Am Soc Nephrol 10: 2219-2223, 1999.","DOI":"10.1681\/ASN.V10102219"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Sadowski CE, Lovric S, Ashraf S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 26: 1279-1289, 2015.","DOI":"10.1681\/ASN.2014050489"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the <i>PAX2<\/i> gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Geneti 9: 358-364, 1995.","DOI":"10.1038\/ng0495-358"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Barua M, Stellacci E, Stella L, et al. Mutations in <i>PAX2<\/i> associate with adult-onset FSGS. J Am Soc Nephrol 25: 1942-1953, 2014.","DOI":"10.1681\/ASN.2013070686"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. McIntosh I, Dreyer SD, Clough MV, et al. Mutation analysis of <i>LMX1B<\/i> gene in nail-patella syndrome patients. Am J Hum Genet 63: 1651-1658, 1998.","DOI":"10.1086\/302165"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Boyer O, Woerner S, Yang F, et al. <i>LMX1B<\/i> mutations cause hereditary FSGS without extrarenal involvement. J Am Soc Nephrol 24: 1216-1222, 2013.","DOI":"10.1681\/ASN.2013020171"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Shimohata H, Miyake Y, Yoshida Y, et al. <i>LMX1B<\/i>-associated nephropathy that showed myelin figures on electron microscopy. CEN Case Rep 10: 588-591, 2021.","DOI":"10.1007\/s13730-021-00612-y"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Witzgall R. Nail-patella syndrome. Pflugers Arch 469: 927-936, 2017.","DOI":"10.1007\/s00424-017-2013-z"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Morello R, Zhou G, Dreyer SD, et al. Regulation of glomerular basement membrane collagen expression by <i>LMX1B<\/i> contributes to renal disease in nail patella syndrome. Nat Genet 27: 205-208, 2001.","DOI":"10.1038\/84853"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Heidet L, Bongers EM, Sich M, et al. <i>In vivo<\/i> expression of putative <i>LMX1B<\/i> targets in nail-patella syndrome kidneys. Am J Pathol 163: 145-155, 2003.","DOI":"10.1016\/S0002-9440(10)63638-3"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Ghoumid J, Petit F, Holder-Espinasse M, et al. Nail-patella syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity. Eur J Hum Genet 24: 44-50, 2016.","DOI":"10.1038\/ejhg.2015.77"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Boerkoel CF, Takashima H, John J, et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 30: 215-220, 2002.","DOI":"10.1038\/ng821"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. L\u00fccke T, Franke D, Clewing JM, et al. Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. Pediatrics 118: e400-e407, 2006.","DOI":"10.1542\/peds.2005-2614"},{"key":"64","unstructured":"64. Warejko JK, Tan W, Daga A, et al. Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 13: 53-62, 2018."},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Keka IS, Mohiuddin, Maede Y, et al. Smarcal1 promotes double-strand-break repair by nonhomologous end-joining. Nucleic Acids Res 43: 6359-6372, 2015.","DOI":"10.1093\/nar\/gkv621"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Esposito T, Lea RA, Maher BH, et al. Unique X-linked familial FSGS with co-segregating heart block disorder is associated with a mutation in the NXF5 gene. Hum Mol Genet 22: 3654-3666, 2013.","DOI":"10.1093\/hmg\/ddt215"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Mallipattu SK, Estrada CC, He JC. The critical role of Kruppel-like factors in kidney disease. Am J Physiol Ren Physiol 312: F259-F265, 2017.","DOI":"10.1152\/ajprenal.00550.2016"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Hayashi K, Sasamura H, Nakamura M, et al. KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria. J Clin Investig 124: 2523-2537, 2014.","DOI":"10.1172\/JCI69557"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Pace JA, Bronstein R, Guo Y, et al. Podocyte-specific KLF4 is required to maintain parietal epithelial cell quiescence in the kidney. Sci Adv 7: eabg6600, 2021.","DOI":"10.1126\/sciadv.abg6600"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Maezawa Y, Onay T, Scott RP, et al. Loss of the podocyte-expressed transcription factor Tcf21\/Pod1 results in podocyte differentiation defects and FSGS. J Am Soc Nephrol 25: 2459-2470, 2014.","DOI":"10.1681\/ASN.2013121307"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Usui J, Yaguchi M, Yamazaki S, et al. Transcription factor 21 expression in injured podocytes of glomerular diseases. Sci Rep 10: 11516, 2020.","DOI":"10.1038\/s41598-020-68422-3"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Kaestner KH, Knochel W, Martinez DE. Unified nomenclature for the winged helix\/forkhead transcription factors. Genes Dev 14: 142-146, 2000.","DOI":"10.1101\/gad.14.2.142"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Rice R, Rice DP, Olsen BR, Thesleff I. Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4. Dev Biol 262: 75-87, 2003.","DOI":"10.1016\/S0012-1606(03)00355-5"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Kume T, Deng KY, Winfrey V, Gould DB, Walter MA, Hogan BLM. The forkhead\/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus. Cell 93: 985-996, 1998.","DOI":"10.1016\/S0092-8674(00)81204-0"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Yang J, Zhang D, Motojima M, et al. Super-enhancer-associated transcription factors maintain transcriptional regulation in mature podocytes. J Am Soc Nephrol 32: 1323-1337, 2021.","DOI":"10.1681\/ASN.2020081177"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Motojima M, Kume T, Matsusaka T. Foxc1 and Foxc2 are necessary to maintain glomerular podocytes. Exp Cell Res 352: 265-272, 2017.","DOI":"10.1016\/j.yexcr.2017.02.016"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Hodgin JB, Borczuk AC, Nasr SH, et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol 177: 1674-1686, 2010.","DOI":"10.2353\/ajpath.2010.090746"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Cao A, Li J, Asadi M, et al. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity. J Clin Invest 131: e141279, 2021.","DOI":"10.1172\/JCI141279"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/1\/62_9336-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T03:25:12Z","timestamp":1673061912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/1\/62_9336-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9336-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"9336-22"}}